Abstract:
Donepezil is the second generation of cholinesterase inhibitors (ChEIs), which has a good effect on mild to moderate Alzheimer's disease (AD). In recent years, there were a lot of studies on the mechanism of donepezil. This paper mainly introduces the diagnosis and treatment situation of AD in China, and the action mechanism of donepezil in the treatment of mild to moderate AD.
Key words:
Alzheimer disease,
Piperidines,
Indans,
Review
摘要:
多奈哌齐是第2 代胆碱酯酶抑制剂,对轻中度阿尔茨海默病有较好疗效。近年关于多奈哌齐作用机制的相关研究较为丰富,本文拟就我国阿尔茨海默病诊断与治疗现状和多奈哌齐治疗轻中度阿尔茨海默病作用机制研究进展进行概述。
关键词:
阿尔茨海默病,
哌啶类,
茚满类,
综述
LI Xin-xin, ZHANG Yun-yun, WANG Bin. Research progress of donepezil for treating mild to moderate Alzheimer's disease[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2017, 17(2): 151-155.
李欣欣, 张云云, 王滨. 多奈哌齐治疗轻中度阿尔茨海默病作用机制研究进展[J]. 中国现代神经疾病杂志, 2017, 17(2): 151-155.